Cargando…

A review of nateglinide in the management of patients with type 2 diabetes

Impaired insulin secretion occurs early in the pathogenesis of type 2 diabetes mellitus (T2DM) and is chronic and progressive, resulting initially in impaired glucose tolerance (IGT) and eventually in T2DM. As most patients with T2DM have both insulin resistance and insulin deficiency, therapy for T...

Descripción completa

Detalles Bibliográficos
Autores principales:	Tentolouris, Nicholas, Voulgari, Christina, Katsilambros, Nicholas
Formato:	Texto
Lenguaje:	English
Publicado:	Dove Medical Press 2007
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2350129/ https://www.ncbi.nlm.nih.gov/pubmed/18200800

Ejemplares similares

Diabetic cardiomyopathy: from the pathophysiology of the cardiac myocytes to current diagnosis and management strategies
por: Voulgari, Christina, et al.
Publicado: (2010)

Moisture Status of the Skin of the Feet Assessed by the Visual Test Neuropad Correlates With Foot Ulceration in Diabetes
por: Tentolouris, Nicholas, et al.
Publicado: (2010)

The ECG Vertigo in Diabetes and Cardiac Autonomic Neuropathy
por: Voulgari, Christina, et al.
Publicado: (2011)

Safety and efficacy of nateglinide/metformin combination therapy in the treatment of type 2 diabetes
por: Israel, Marc K, et al.
Publicado: (2008)

Efficacy and safety of nateglinide plus vildagliptin combination therapy compared with switching to vildagliptin in type 2 diabetes patients inadequately controlled with nateglinide
por: Kudo‐Fujimaki, Kyoko, et al.
Publicado: (2013)

Differential Effects of Two Isoenergetic Meals Rich in Saturated or Monounsaturated Fat on Endothelial Function in Subjects With Type 2 Diabetes
por: Tentolouris, Nicholas, et al.
Publicado: (2008)

The Effect of Ingested Macronutrients on Postprandial Ghrelin Response: A Critical Review of Existing Literature Data
por: Koliaki, Chrysi, et al.
Publicado: (2010)

Metabolic syndrome is not associated with reduction in aortic distensibility in subjects with type 2 diabetes mellitus
por: Tentolouris, Nicholas, et al.
Publicado: (2008)

The role of nateglinide and repaglinide, derivatives of meglitinide, in the treatment of type 2 diabetes mellitus
por: Guardado-Mendoza, Rodolfo, et al.
Publicado: (2013)

Cigarette Smoking Is Associated with Prolongation of the QTc Interval Duration in Patients with Type 2 Diabetes Mellitus
por: Thomakos, Petros, et al.
Publicado: (2013)

Efficacy and safety of repaglinide vs nateglinide for treatment of Japanese patients with type 2 diabetes mellitus
por: Kawamori, Ryuzo, et al.
Publicado: (2012)

Assessment of the Spatial QRS-T Angle by Vectorcardiography: Current Data and Perspectives
por: Voulgari, Christina, et al.
Publicado: (2009)

Study of Postprandial Lipaemia in Type 2 Diabetes Mellitus: Exenatide versus Liraglutide
por: Voukali, Maria, et al.
Publicado: (2014)

Arterial Stiffness Is Inversely Related to Plasma Adiponectin Levels in Young Normotensive Patients With Type 1 Diabetes
por: Tsiakou, Afroditi, et al.
Publicado: (2013)

Relationship between Autonomic Nervous System Function and Continuous Interstitial Glucose Measurement in Patients with Type 2 Diabetes
por: Kalopita, Stavroula, et al.
Publicado: (2014)

Autonomic Neuropathy in Diabetes Mellitus and Obesity: An Update
por: Katsilambros, Nicholas L., et al.
Publicado: (2011)

Postprandial endothelial dysfunction in subjects with new-onset type 2 diabetes: an acarbose and nateglinide comparative study
por: Kato, Toru, et al.
Publicado: (2010)

The Spatial QRS-T Angle: Implications in Clinical Practice
por: Voulgari, Christina, et al.
Publicado: (2013)

Cardiac Autonomic Function Correlates with Arterial Stiffness in the Early Stage of Type 1 Diabetes
por: Liatis, S., et al.
Publicado: (2011)

The effect of slow spaced eating on hunger and satiety in overweight and obese patients with type 2 diabetes mellitus
por: Angelopoulos, Theodoros, et al.
Publicado: (2014)

Comparison of nateglinide and gliclazide in combination with metformin, for treatment of patients with Type 2 diabetes mellitus inadequately controlled on maximum doses of metformin alone
por: Ristic, S, et al.
Publicado: (2006)

Formulation and In Vitro Evaluation of Bilayer Tablets of Nebivolol Hydrochloride and Nateglinide for the Treatment of Diabetes and Hypertension
por: Ryakala, Harika, et al.
Publicado: (2015)

Development and validation of analytical method for the estimation of nateglinide in rabbit plasma
por: Pani, Nihar Ranjan, et al.
Publicado: (2012)

Comparison of sitagliptin with nateglinide on postprandial glucose and related hormones in drug-naïve Japanese patients with type 2 diabetes mellitus: A pilot study
por: Tanimoto, Masumi, et al.
Publicado: (2015)

Helical‐Like Assembly of Nateglinide as Coating for Oral Delivery of Insulin and Their Synergistic Prevention of Diabetes Mellitus
por: Li, Yanfei, et al.
Publicado: (2023)

Effects of Glucose Load and Nateglinide Intervention on Endothelial Function and Oxidative Stress
por: Wang, Leilei, et al.
Publicado: (2013)

Repositioning the Role of Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand (TRAIL) on the TRAIL to the Development of Diabetes Mellitus: An Update of Experimental and Clinical Evidence
por: Koliaki, Chrysi, et al.
Publicado: (2022)

Abdominal pain in an adult with Type 2 diabetes: A case report
por: Panagoulias, George, et al.
Publicado: (2008)

Nateglinide is Effective for Diabetes Mellitus with Reactive Hypoglycemia in a Child with a Compound Heterozygous ABCC8 Mutation
por: Saito-Hakoda, Akiko, et al.
Publicado: (2012)

Effects of nateglinide and rosiglitazone on pancreatic alpha- and beta-cells, GLP-1 secretion and inflammatory markers in patients with type 2 diabetes: randomized crossover clinical study
por: Tostes, Glauce Cordeiro Ulhôa, et al.
Publicado: (2016)

Evaluation of the effect of MTNR1B rs10830963 gene variant on the therapeutic efficacy of nateglinide in treating type 2 diabetes among Chinese Han patients
por: Song, Jin-Fang, et al.
Publicado: (2021)

Glucose-dependent and Glucose-sensitizing Insulinotropic Effect of Nateglinide: Comparison to Sulfonylureas and Repaglinide
por: Hu, Shiling, et al.
Publicado: (2001)

Development and in vitro/in vivo evaluation of controlled release provesicles of a nateglinide–maltodextrin complex
por: Sahoo, Ranjan Ku., et al.
Publicado: (2014)

Important Considerations for the Treatment of Patients with Diabetes Mellitus and Heart Failure from a Diabetologist’s Perspective: Lessons Learned from Cardiovascular Outcome Trials
por: Koliaki, Chrysi, et al.
Publicado: (2019)

Effectiveness of Nateglinide on In Vitro Insulin Secretion from Rat Pancreatic Islets Desensitized to Sulfonylureas
por: Hu, Shiling, et al.
Publicado: (2001)

Simultaneous Determination of Metformin, Nateglinide and Gliclazide in Pharmaceutical Preparations Using Micellar Liquid Chromatography
por: El-Wasseef, Dalia Rashad
Publicado: (2012)

PPARD rs2016520 (T/C) and NOS1AP rs12742393 (A/C) polymorphisms affect therapeutic efficacy of nateglinide in Chinese patients with type 2 diabetes mellitus
por: Wang, Tao, et al.
Publicado: (2021)

Repaglinide, but Not Nateglinide Administered Supraspinally and Spinally Exerts an Anti-Diabetic Action in D-Glucose Fed and Streptozotocin-Treated Mouse Models
por: Sim, Yun-Beom, et al.
Publicado: (2013)

Intensification of insulin therapy in patients with type 2 diabetes: a retrospective, non- interventional cohort study of patients treated with insulin glargine or biphasic human insulin in daily clinical practice
por: Tentolouris, Nicholas, et al.
Publicado: (2013)

Characterization of binding by repaglinide and nateglinide with glycated human serum albumin using high‐performance affinity microcolumns
por: Ovbude, Susan T., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_d1cog1m4tqrcv0mcas8up026tn